BRIEF published on 04/02/2024 at 17:05, 2 years 5 months ago Bux Pain Management Launches SynchroMed III Pain Pump FDA Approval Chronic Pain Treatment SynchroMed III Pump Pain Management Technology Opioid Alternative
BRIEF published on 04/02/2024 at 17:05, 2 years 5 months ago Bux Pain Management lance la pompe anti-douleur SynchroMed III Traitement De La Douleur Chronique Approbation De La FDA Pompe SynchroMed III Technologie De Gestion De La Douleur Alternative Aux Opioïdes
PRESS RELEASE published on 04/02/2024 at 17:00, 2 years 5 months ago Bux Pain Management Introduces Innovative SynchroMed III Pain Pump to Its Practice Bux Pain Management implements SynchroMed III intrathecal drug delivery system, revolutionizing pain management therapy with enhanced safety and efficiency Innovative Technology Pain Management Chronic Pain Bux Pain Management SynchroMed III
PRESS RELEASE published on 12/12/2023 at 16:00, 2 years 8 months ago Bux Pain Management Welcomes Mandi Tomazic, Board-Certified Family Nurse Practitioner, to Its Esteemed Team
Published on 09/12/2026 at 02:35, 10 hours 55 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 30 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 25 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 5 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 30 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 5 hours 59 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 15 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 19 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 45 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 14 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
